GoodRx Holdings Inc - Class A

Research GoodRx Holdings Inc - Class A (GDRX) on Bullrun: valuation model: 33.1% overvalued, market cap USD 965.22M, P/E 48.7. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGDRX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryHealth Information Services
• CurrencyUSD
• Valuation signal33.1% overvalued
• Market capUSD 965.22M
• P/E48.7
• Financial periodFY2025
• RevenueUSD 796.85M
• Revenue growth0.6%
• Net incomeUSD 30.40M
• Free cash flowUSD 164.38M

Valuation Snapshot

Bullrun's latest valuation model marks GoodRx Holdings Inc - Class A as 33.1% overvalued; latest market cap is USD 965.22M; P/E is 48.7.

About GoodRx Holdings Inc - Class A

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.

Frequently asked questions

Is GoodRx Holdings Inc - Class A overvalued or undervalued?

Bullrun's valuation model currently marks GoodRx Holdings Inc - Class A as 33.1% overvalued.

What is GoodRx Holdings Inc - Class A's market cap?

GoodRx Holdings Inc - Class A's market capitalization is USD 965.22M.

What is GoodRx Holdings Inc - Class A's P/E ratio?

GoodRx Holdings Inc - Class A's price-to-earnings (P/E) ratio is 48.7.

What does GoodRx Holdings Inc - Class A do?

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.